While it has been proposed that older women may present with more aggressive or higher-risk disease [32, 33], other studies have documented that elderly women have less aggressive disease and a more favorable tumor marker profile (ER+ and/or PR+, HER2/neu−, and decreased levels of cell proliferation markers) [34, 35]. This evidence concerns the gene ERBB2 and neoplasm.